Jason
Adair
Chief Business Officer
Jason Adair joined Liquidia in 2016 where he serves as Chief Business Officer. In this role, he is responsible for corporate development activities including strategy, investor relations, communications and the pursuit of collaboration and licensing opportunities for the company. Prior to joining Liquidia, Jason led business development efforts at BioCryst Pharmaceuticals as its Executive Director of Corporate Development. His work included the commercial launch and subsequent partnering of the company’s first FDA approved drug. Jason also worked at MedImmune/AstraZeneca in roles of increasing responsibility in business development, marketing and operations. Before entering the pharmaceutical industry, Jason worked as an analytical chemist for Syngenta and served as an officer in the United States Army. He holds a Master of Business Administration from the Tuck School of Business at Dartmouth College and a Bachelor of Science in Chemistry from Wake Forest University.
Jason Adair joined Liquidia in 2016 where he serves as Chief Business Officer. In this role, he is responsible for corporate development activities including strategy, investor relations, communications and the pursuit of collaboration and licensing opportunities for the company. Prior to joining Liquidia, Jason led business development efforts at BioCryst Pharmaceuticals as its Executive Director of Corporate Development. His work included the commercial launch and subsequent partnering of the company’s first FDA approved drug. Jason also worked at MedImmune/AstraZeneca in roles of increasing responsibility in business development, marketing and operations. Before entering the pharmaceutical industry, Jason worked as an analytical chemist for Syngenta and served as an officer in the United States Army. He holds a Master of Business Administration from the Tuck School of Business at Dartmouth College and a Bachelor of Science in Chemistry from Wake Forest University.